We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $69.2B
1-Year Est. Return 41.24%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$56.7B
AUM Growth
+$8.88B
Cap. Flow
+$7.92B
Cap. Flow %
13.98%
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Avg Time Held
24 quarters
Top 10 Avg Time Held
22.8 quarters
Top 20 Avg Time Held
20.5 quarters

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$779M
2
AAPL icon
Apple
AAPL
+$539M
3
MSFT icon
Microsoft
MSFT
+$522M
4
META icon
Meta Platforms (Facebook)
META
+$487M
5
TSLA icon
Tesla
TSLA
+$414M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$189M
2
CHRW icon
C.H. Robinson
CHRW
+$55.4M
3
FTNT icon
Fortinet
FTNT
+$55M
4
ABBV icon
AbbVie
ABBV
+$35.7M
5
NEE icon
NextEra Energy
NEE
+$32.6M

Sector Composition

Rank Sector Weight
1 Technology 37.38%
2 Communication Services 10.74%
3 Consumer Discretionary 10.59%
4 Industrials 8.58%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ATAI icon
1926
DELISTED
AtaiBeckley Inc
ATAI
$65.6K ﹤0.01%
+16,042
New +$75.7K
2025 Q4
0 quarters
SIGA icon
1927
SIGA Technologies
SIGA
$236M
$65.1K ﹤0.01%
+10,659
New +$75.8K
2025 Q4
0 quarters
ACRS icon
1928
Aclaris Therapeutics
ACRS
$564M
$64.9K ﹤0.01%
21,553
+6,734
+45% +$17K
2025 Q2
2 quarters
ORGO icon
1929
Organogenesis Holdings
ORGO
$166M
$64.7K ﹤0.01%
12,483
+804
+7% +$3.9K
2024 Q3
5 quarters
CTOS icon
1930
Custom Truck One Source
CTOS
$2.1B
$63.4K ﹤0.01%
11,000
+692
+7% +$4.22K
2024 Q4
4 quarters
ARKO icon
1931
ARKO Corp
ARKO
$461M
$62.7K ﹤0.01%
13,809
+667
+5% +$2.99K
2023 Q2
10 quarters
EB icon
1932
DELISTED
Eventbrite
EB
$61.5K ﹤0.01%
13,825
+892
+7% +$2.76K
2023 Q2
10 quarters
BGS icon
1933
B&G Foods
BGS
$195M
$61.3K ﹤0.01%
14,259
+1,064
+8% +$4.75K
2022 Q4
12 quarters
SRTA icon
1934
Strata Critical Medical Inc
SRTA
$401M
$60K ﹤0.01%
12,479
+1,368
+12% +$6.62K
2024 Q3
5 quarters
PBYI icon
1935
Puma Biotechnology
PBYI
$531M
$59.9K ﹤0.01%
+10,062
New +$53.4K
2025 Q4
0 quarters
ACCO icon
1936
Acco Brands
ACCO
$414M
$59.6K ﹤0.01%
15,972
+1,028
+7% +$3.81K
2020 Q2
22 quarters
RC icon
1937
Ready Capital
RC
$215M
$59.1K ﹤0.01%
27,124
-4,068
-13% -$11.4K
2021 Q4
16 quarters
AURA icon
1938
Aura Biosciences
AURA
$678M
$59K ﹤0.01%
+10,830
New +$64.3K
2025 Q4
0 quarters
CADL icon
1939
Candel Therapeutics
CADL
$761M
$58.9K ﹤0.01%
+10,433
New +$56.1K
2025 Q4
0 quarters
AVIR icon
1940
Atea Pharmaceuticals
AVIR
$413M
$58.7K ﹤0.01%
16,440
+506
+3% +$1.61K
2021 Q1
19 quarters
HLLY icon
1941
Holley
HLLY
$302M
$57.7K ﹤0.01%
13,961
+3,777
+37% +$13.6K
2024 Q4
4 quarters
BYND icon
1942
Beyond Meat
BYND
$132M
$57.5K ﹤0.01%
2,336
+1,916
+456% +$79.9K
2024 Q3
5 quarters
DNUT icon
1943
Krispy Kreme
DNUT
$514M
$56.4K ﹤0.01%
14,036
+845
+6% +$3.34K
2023 Q2
10 quarters
CDZI icon
1944
Cadiz
CDZI
$290M
$56.4K ﹤0.01%
+10,048
New +$53.9K
2025 Q4
0 quarters
ADCT icon
1945
ADC Therapeutics
ADCT
$221M
$55.5K ﹤0.01%
15,727
+3,339
+27% +$13.5K
2024 Q3
5 quarters
PTLO icon
1946
Portillo's
PTLO
$292M
$55.3K ﹤0.01%
12,188
+2,043
+20% +$10.7K
2024 Q3
5 quarters
OEC icon
1947
Orion
OEC
$326M
$53.5K ﹤0.01%
+10,131
New +$55K
2025 Q4
0 quarters
BRBS icon
1948
Blue Ridge Bankshares
BRBS
$344M
$52.6K ﹤0.01%
12,326
+791
+7% +$3.43K
2025 Q2
2 quarters
ALLO icon
1949
Allogene Therapeutics
ALLO
$504M
$52.1K ﹤0.01%
38,034
+4,204
+12% +$5.54K
2019 Q4
24 quarters
SVC
1950
Service Properties Trust
SVC
$926M
$52K ﹤0.01%
5,650
+363
+7% +$3.65K
2013 Q2
50 quarters

Similar funds

ProShare Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.

  • ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
  • ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
  • ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
  • ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
  • ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
  • ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
  • ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.

Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.